Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

The biochemistry, metabolism and inherited defects of the pentose phosphate pathway: a review.

Wamelink MM, Struys EA, Jakobs C.

J Inherit Metab Dis. 2008 Dec;31(6):703-17. doi: 10.1007/s10545-008-1015-6. Epub 2008 Nov 8. Review.

PMID:
18987987
2.

The unexplored potential of the pentose phosphate pathway in health and disease.

Berry GT.

J Inherit Metab Dis. 2008 Dec;31(6):661. doi: 10.1007/s10545-008-9971-4. No abstract available.

PMID:
19015949
3.

Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure.

Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT.

J Pediatr Gastroenterol Nutr. 2011 Jan;52(1):113-6. doi: 10.1097/MPG.0b013e3181f50388. No abstract available.

PMID:
21119539
4.

Transaldolase deficiency in a two-year-old boy with cirrhosis.

Wamelink MM, Struys EA, Salomons GS, Fowler D, Jakobs C, Clayton PT.

Mol Genet Metab. 2008 Jun;94(2):255-8. doi: 10.1016/j.ymgme.2008.01.011. Epub 2008 Mar 10.

PMID:
18331807
5.

[A newly discovered metabolic diseases due to defects in the pentose pathway].

Tylki-Szymańska A, Stradomska TJ.

Postepy Biochem. 2011;57(2):168-71. Review. Polish.

PMID:
21913417
6.

Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy.

Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS.

Am J Hum Genet. 2004 Apr;74(4):745-51. Epub 2004 Feb 25.

7.

Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway.

Verhoeven NM, Huck JH, Roos B, Struys EA, Salomons GS, Douwes AC, van der Knaap MS, Jakobs C.

Am J Hum Genet. 2001 May;68(5):1086-92. Epub 2001 Mar 27.

8.

Transaldolase deficiency influences the pentose phosphate pathway, mitochondrial homoeostasis and apoptosis signal processing.

Qian Y, Banerjee S, Grossman CE, Amidon W, Nagy G, Barcza M, Niland B, Karp DR, Middleton FA, Banki K, Perl A.

Biochem J. 2008 Oct 1;415(1):123-34. doi: 10.1042/BJ20080722.

PMID:
18498245
9.

The pathogenesis of transaldolase deficiency.

Perl A.

IUBMB Life. 2007 Jun;59(6):365-73. Review.

10.

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway.

Stincone A, Prigione A, Cramer T, Wamelink MM, Campbell K, Cheung E, Olin-Sandoval V, Grüning NM, Krüger A, Tauqeer Alam M, Keller MA, Breitenbach M, Brindle KM, Rabinowitz JD, Ralser M.

Biol Rev Camb Philos Soc. 2015 Aug;90(3):927-63. doi: 10.1111/brv.12140. Epub 2014 Sep 22. Review.

12.

Quantification of sugar phosphate intermediates of the pentose phosphate pathway by LC-MS/MS: application to two new inherited defects of metabolism.

Wamelink MM, Struys EA, Huck JH, Roos B, van der Knaap MS, Jakobs C, Verhoeven NM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Aug 25;823(1):18-25. Epub 2005 Jan 23.

PMID:
16055050
13.

Regulation of the pentose phosphate pathway in cancer.

Jiang P, Du W, Wu M.

Protein Cell. 2014;5(8):592-602. doi: 10.1007/s13238-014-0082-8. Epub 2014 Jul 12. Review.

14.

Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.

Payen VL, Porporato PE, Baselet B, Sonveaux P.

Cell Mol Life Sci. 2016 Apr;73(7):1333-48. doi: 10.1007/s00018-015-2098-5. Epub 2015 Dec 1. Review.

PMID:
26626411
15.

Nephrological abnormalities in patients with transaldolase deficiency.

Loeffen YG, Biebuyck N, Wamelink MM, Jakobs C, Mulder MF, Tylki-Szymańska A, Fung CW, Valayannopoulos V, Bökenkamp A.

Nephrol Dial Transplant. 2012 Aug;27(8):3224-7. doi: 10.1093/ndt/gfs061. Epub 2012 Apr 17.

PMID:
22510381
16.

Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency.

Huck JH, Struys EA, Verhoeven NM, Jakobs C, van der Knaap MS.

Clin Chem. 2003 Aug;49(8):1375-80.

17.

Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?

Boros LG, Lee PW, Brandes JL, Cascante M, Muscarella P, Schirmer WJ, Melvin WS, Ellison EC.

Med Hypotheses. 1998 Jan;50(1):55-9.

PMID:
9488183
18.

Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose.

Lee WN, Boros LG, Puigjaner J, Bassilian S, Lim S, Cascante M.

Am J Physiol. 1998 May;274(5 Pt 1):E843-51.

PMID:
9612242
19.
20.

Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase.

Perl A, Hanczko R, Telarico T, Oaks Z, Landas S.

Trends Mol Med. 2011 Jul;17(7):395-403. doi: 10.1016/j.molmed.2011.01.014. Epub 2011 Mar 2. Review.

Supplemental Content

Support Center